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Abstract 
In order to further investigate the molecular mechanisms that regulate 
oligodendrocyte (OC) survival, we utilized microarrays to characterize changes in OC 
gene expression after exposure to the cytokines neurotrophin3, insulin or leukemia 
inhibitory factor (LIF) in vitro. We identified and validated the induction and 
secretion of the neuropeptide galanin in OCs, specifically in response to LIF. We next 
established that galanin is an OC survival factor and showed that autocrine or 
paracrine galanin secretion mediates LIF-induced OC survival in vitro. Using the 
cuprizone model of demyelination, we showed that galanin is up-regulated in OCs in 
this animal model of central demyelination and that oligodendroglial galanin 
expression is significantly regulated by endogenous LIF in this context. We also 
showed that knock-out of galanin reduces OC survival and exacerbates callosal 
demyelination in the cuprizone model.  
These findings suggest a potential role for the use of galanin agonists in the treatment 
of human demyelinating diseases.  
 
Introduction 
The oligodendrocyte (OC) is the specialized glial cell within the central nervous 
system (CNS) that is responsible for producing myelin and is targeted in central 
demyelinating disease. Therefore, an understanding of the molecular mechanisms 
regulating OC survival and myelin maintenance could inform novel therapeutic 
strategies. 
 
A limited number of growth factor families, including the neurotrophins, insulin and 
insulin-like growth factors, as well as members of the interleukin-6 family, are known 
to enhance OC survival, and generally do not act synergistically (Barres et al. 1992; 
Barres et al. 1993; Casaccia-Bonnefil 2000; Kahn and De Vellis 1994). The molecular 
mechanisms by which these factors influence OC survival are incompletely 
understood. On the one hand, there is considerable evidence that a number of key 
signaling pathways are activated in response to receptor binding and activation by 
these cytokines, including the signal transducer and activator of transcription (STATs) 
1 and 3 (Boulton et al. 1994; Sadowski et al. 1993);	Akt (Alonzi et al. 2001) and 
Mek/MAPK pathways (Ernst et al. 1999; Tomida et al. 1999). It remains uncertain, 
however, whether these signaling pathways are used in a generic sense by each of the 
relevant growth factor families in order to promote OC survival, or whether individual 
growth factor families ultimately act by disparate mechanisms.   
 
In this study, we examined gene expression changes in OCs following incubation with 
three cytokines known to promote their survival, namely insulin (Barres et al, 1992; 
1993), neurotrophin-3 (NT3, Barres et al, 1993), and the interleukin-6 family member 
leukemia inhibitory factor (LIF, Barres et al, 1993). Little concordance was found 
between genes induced by LIF, insulin or neurotrophin-3.  Interestingly, one response 
unique to LIF was the induction of galanin, a neuropeptide with known trophic and 
survival roles in neurons.   
 
Galanin is a 29 amino acid neuropeptide that was originally isolated from porcine 
intestine. Under normal basal physiological conditions, galanin is synthesized and 
secreted by a number of neuronal populations, where it predominantly functions as an 
inhibitor of synaptic transmission.  The functions of galanin in OCs are not well 
defined, but we have previously shown that galanin is exclusively up regulated in 
OCs in acute lesional tissue using the murine MOG35-55 experimental autoimmune 
encephalomyelitis model (EAE) (Wraith et al. 2009).  Furthermore, in the same study, 
using galanin-knockout (Gal-KO) and galanin-overexpressing transgenic mice we 
showed that depletion of endogenous galanin expression markedly worsens disease 
outcome in EAE, whereas galanin overexpressing transgenics exhibited abrogated 
disease. A recently published study also suggests that transgenic mice with increased 
systemic galanin levels due to galanin overexpression in the anterior pituitary are 
relatively resistant to cuprizone-mediated callosal demyelination and exhibit a 2.5 
fold increase in GST-pi positive callosal OC numbers at the time of maximal 
demyelination (Zhang et al. 2012).  It remains unclear however if the transgenic 
systemic overexpression of galanin acts directly on OCs to promote these beneficial 
effects. 
      
Using primary OC cultures from Gal-KO and wildtype mice, we investigate if 
galanin, itself, acts as a survival factor for OCs. Furthermore, in  juxtaposition to 
previous studies, we investigate if an absence of endogenous galanin increases the 
severity of demyelination and OC loss induced by systemic cuprizone ingestion, to 
determine if the upregulation of galanin in wild-type OC is also associated with 
reduced disease-related demyelination in vivo.  
 
Materials and Methods: 
 
All experiments were conducted under the auspices of and were approved by the 
Howard Florey Institute (HFI) Animal Ethics Committees and in fulfilment of the 
National Health and Medical Research Council of Australia Animal Research 
guidelines. 
 
Mice 
The Gal-KO mice on the 129OlaHsd background were as previously described 
(Wynick et al. 1998), the PLP-dsRED transgenic mice were generated by Dr Frank 
Kirchhoff (backcrossed 12 generations to C57Bl6 in our laboratory) and the LIF-
knockout and CNTF-knockout mouse lines on the C57Bl6 background were a kind 
gift from Professor Michael Sendtner, Wuerzburg (Bugga et al. 1998; Masu et al. 
1993). Littermate wild-type controls were used for all cuprizone experiments. For 
cuprizone-induced demyelination, 9-week-old mice were fed ad libitum a diet of 
powdered feed (Barastoc; Ridley AgriProducts, Pakenham, Victoria) mixed with 
cuprizone (Sigma-Aldrich) at 0.2% (w/w) for 18 days. At experimental end-point, the 
mice were killed by intraperitoneal injection of pentobarbitone.  
For immunohistochemistry processing, mice were transcardially perfused with 20 mL 
of PBS, followed by 20 mL of 4% paraformaldehyde (PFA) solution. The brains were 
dissected out and postfixed in 4% PFA solution overnight and then cryoprotected in 
20% sucrose overnight prior to blocking in Tissue-Tek (Sakura). Serial 10 µm coronal 
sections were cut on a cryostat (Leica Microsystems).  
For electron microscopic evaluation of caudal callosal myelinated axon numbers, 
mice were transcardially perfused with 4% PFA/2.5% gluteraldehyde in 0.1 M 
sodium cacodylate buffer. The caudal callosal region was dissected and post-fixed in 
2% Osmium tetraoxide/1.5% potassium ferricyanide then routinely processed for EM 
and embedded in Spurr's resin. Samples were sectioned with a Reichert Ultracut S 
ultramicrotome for cross-sections at 0.5 μm for methylene-blue staining. For each 
callosal section examined, three images from non-overlapping areas of the corpus 
callosum corresponding to approximately Bregma 0.38 were acquired at 100 times 
magnification on a Zeiss Axioplan 2 Imaging system (Axiovision Software Release 
4.4), and 17400 μm2 sections from the centre of each image were used to count the 
number of myelinated axons (see Fig 6). The three individual counts per animal were 
averaged and expressed as the number of myelinated axons/section.  
 
Rat astrocyte cell cultures 
Primary mixed glial cultures were prepared from the cortices of P1-2 Sprague-Dawley 
rat pups as previously described (McCarthy and de Vellis 1980, modified by Binder et 
al, 2008).  .  Once grown to confluence (day 7), microglia and OCs were removed 
from the mixed glial culture by shaking the culture at 100 rpm for two hours and 180 
rpm overnight respectively.  Astroglial cultures were further purified by gentle 
percussion to achieve a purity of >95%.  Astrocytes were maintained in DMEM 10. 
For passaging, purified astrocytes were trypsinized (1:1000 of 2.5% stock, Stratagene) 
for 8 minutes at 37°C/5% CO2. The reaction was stopped with the addition of 
DMEM10.  Cells were counted using a haemocytometer and plated in appropriate 
PDL-coated 10 cm dishes for experimentation.  
 
Oligodendrocyte cell cultures 
We purified rat OCs from P6 rat optic nerve oligodendrocyte precursor cells (OPCs) 
as previously described (Barres et al. 1992; Binder et al. 2008).  
Mouse OPCs were isolated from P6 mouse cortex like their rat counterparts (Cahoy et 
al. 2008), with the following modifications. The cells were immunopanned over three 
sequential Anti BSL1/Griffonia simplicifolia Lectin 1 (Vector Labs L-1100) coated 
plates followed by positive selection with an anti-PDGFRa antibody (Research 
Diagnostics) coated plate, and the rat SATO was modified by inclusion of 20µl/ml of 
B27 (Gibco)    
 
RNA preparation for Affymetrix arrays and real-time PCR 
For the gene array experiments, the cells were washed twice with SATO then placed 
in SATO (without growth factors, or with 5ng/mL NT3, or 5µg/mL Insulin, or 
100ng/ml LIF) for 24 hours before harvesting. For real-time PCR validation, rat OC 
were plated in SATO and exposed for either 8 or 24 hrs to LIF (100ng/ml) or insulin 
(5µg/mL).  
For both array and real-time PCR experiments, OC RNA was then isolated using the 
Qiagen RNeasy Mini Kit (Animal cell –I) according to the manufacturer’s 
instructions. Ten µg of total RNA was subjected to DNase treatment to remove any 
remaining DNA and the Qiagen RNeasy Mini Kit (RNA Cleanup) was used to purify 
RNA that was eluted in a final volume of 30μl in RNase-free water.  RNA 
concentration and purity were quantified using a Nanodrop spectrophotometer 
(Biolab, Australia). 
 
Affymetrix Micro Array  
For micro array analysis RNA from three independent biological replicate 
experiments were harvested for each treatment. One µg of total RNA was reverse 
transcribed using the 3' IVT Express Kit (Affymetrix) and hybridized to the Rat 
Genome 230 2.0 GeneChip (Affymetrix) using the GeneChip Hybridization, Wash, 
and Stain Kit (Affymetrix) according to manufactures instructions at the Australian 
Genome Research Facility (AGRF, Parkville). Microarray data was analysed using 
Partek® genomics suite version 6.5 (6.3) (Partek Inc, St Louis, MO, USA). One 
control treatment sample was excluded as it was identified as an outlier during quality 
control analysis of the expression data. An ANOVA model, including both the 
treatment and replicate groups, was performed, identifying a typical batch effect 
within the replicate experiments, which were hybridised on different days. However 
the experiment was a balanced designed with each batch containing each treatment 
group, and was accounted for in the 2 way ANOVA. Lists of significantly changed 
probe sets (p values less than 0.01 and fold changes of 2 or greater) were generated 
for each comparison between control and treatment groups (supplementary tables S1-
4). 
 
Real-time PCR 
One µg of RNA was reverse transcribed into cDNA using Taqman Reverse 
Transcriptase. Five µL of cDNA from each reverse transcriptase reaction was added 
to 1µL of forward primer (20µM) and 1µL of reverse primers (20µM), 5.5 µL of 
nuclease-free water and 12.5 µL 2 x SYBRgreen PCR Mastermix (Applied 
Biosystems 4309155). Primers and oligonucleotide probes were designed from cDNA 
sequences (GenBank) using Primer Express software (Applied Biosystems). Primers 
were BLAST-searched to verify specificity. Real Time-PCR (RTPCR) was performed 
using a Prism 7500 fast real-time PCR machine (Applied Biosystems). The following 
RTPCR conditions were used: 40 cycles of 50oC for 2 mins, 95oC for 10 mins, 95oC 
for 15 secs, and 60oC for 1 min, and for the dissociation curve analysis, 1 cycle at 
95°C for 15 sec, 1 cycle at 60°C for 20 sec, and 1 cycle at 95°C for 15 sec. The real 
time detection cycle was normalised to the 18S signal in each case (Livak and 
Schmittgen, 2001). Primer sequences for real-time PCR were: Secretogranin 2 
Forward 5’-GCAGGGAAGGGAACATCTTG-3’, Reverse 5’-
AAAGAAGGGAAATTGGGCATTAA-3’; VGF Forward 5’-
GCCTCGTCCCCATCTAGTTTC -3’ Reverse 5’-
TCACACGATTAAATAGAACAGCTTTTC-3’; IGF 2 Forward 5’-
TGCAGTTCTCCCCATCATAGG-3’ Reverse 5’-
ACAAGATGGAGGGCCACACTAG -3’; Galanin Forward 5’-
GGAAGTGGAGGAAGGGAGACTAG -3’ Reverse 5’-
AAACTCCATTATAGTGCGGACGATA -3’; Galanin Receptor 1 (Rat) Forward 5’-
TGGACAAAACTTAGCCACGTAGTTAA -3’, Reverse 5’-
GCTCATTCGGAATCAAGCATC -3’; Galanin Receptor 2 (Rat) Forward 5’-
CCTGTGTCAACCCCATCGTT -3’, Reverse 5’-GCGCAGATTTTGCGGAAA -3’, 
Galanin Receptor 3 (Rat) Forward 5’-GCAGTGCCTGTGATCTTTGC -3’, Reverse 
5’ GCCAACACCAGCCCATTG -3’ 
 
Low density survival assay 
After 24 hours maturation post PDGF withdrawal, OCs were harvested and plated on 
to PDL-coated 24-well plates, at 100 cells/well, 20 wells per condition, in 10 µl of 
media, and then incubated at 37oC for 5 minutes to settle. Then, 500µl of pre-warmed 
SATO medium, either with or without addition of single growth factors NT3 
(5ng/mL), Insulin (5µg/mL), LIF (100ng/ml) or recombinant rat galanin (Bachem H-
7450, at doses of 0.01-10nM). All plates were then incubated at 37oC for 48 hours. 
After 48 or 72 hr, calcein AM (4 mM, Invitrogen) and Ethidium homodimer (4mM, 
Invitrogen) were added to each well and incubated at RT for 30 minutes to identify 
live/dead cells. Live (green) cells were then counted using an inverted fluorescence 
microscope.  
 
High density survival assay 
After 24 hrs maturation post PDGF withdrawal, OC were harvested and plated at 3 
million cells/dish in 10cm PDL-coated plastic dishes, in a total volume of 8 ml of 
Sato containing NT3 (5ng/ml) and incubated for 48,72 or 96 hrs with or without the 
addition of LIF (100ng/ml). Calcein AM (4 mM, Invitrogen) and Ethidium 
homodimer (4mM, Invitrogen) were added to each dish and incubated at RT for 30 
minutes to identify live/dead cells. Live (green) cells were then counted using an 
inverted fluorescence microscope. Ten random fields were counted for each 
condition.  
 
Oligodendrocyte siRNA 
For siRNA transfection experiments, rat OPCs were expanded through two passages 
into 10 PDL-coated T75 flasks, trypsinised as above and 12 million cells were re-
suspended in 410 µl of rat OC nucleofector solution (Amaxa Biosystems). Then, 100 
µl aliquots were transfected (ie. 3 million cells per trial) according to the 
manufacturer’s instructions on program O-17 using an Amaxa Nucleofactor machine, 
with 1 µl of siRNA solutions directed against galanin, cyclophilin B or non-targeting 
siRNA solution. After the transfection, 500microlitres of SATO media was added and 
the cells transferred to 15cm PDL-coated plates in a total volume of 15 ml of SATO 
with NT3 (5ng/ml), and incubated with or without LIF (100ng/ml) for 48 or 72 hrs. 
The siRNA were siCONTROL Cyclophilin B siRNA (D-001136-01-05), 
siCONTROL Non-targeting siRNA (D-001210-01-05) or rat galanin siGenome smart 
pool (three siRNA mix), all from Dharmacon RNA technologies, diluted in siRNA 
buffer to a final siRNA concentration of 20 µM.  
In order to establish siRNA efficacy, in 4 independent trials, galanin siRNA reduced 
galanin mRNA expression in OC 48 hrs post-transfection by an average of 72% 
compared to non-targeting siRNA transfected cells (range: 57-86%) and by an 
average of 64% compared to cyclophilin B siRNA transfected cells (range: 56-72%) 
(data not shown). For these experiments, RNA was extracted from transfected cells 
using the QIAGEN RNeasy Minikit according to the manufacturer’s instructions after 
washing the plates twice with PBS. The galanin RNA expression was measured using 
real-time PCR as above. The real time detection cycle was normalized to the 18S 
signal in each case.  
 
 
Tumor necrosis factor alpha induced cell death assay 
To examine the effect of galanin on cell survival, CG4 cells were seeded at a density 
of 5,000 cells/well in 8-well chamber slides.  Cells were maintained in SATO media 
for 72 hours in the presence of: (1) no additional factors, (2) recombinant rat galanin 
(1nM), recombinant rat tumor necrosis factor alpha (100ng/ml R&D systems) and 
both galanin (1nM) and TNFa (100ng/ml). Ethidium homodimer-1 (4 mM; 
Invitrogen) and calcein AM (4 mM; Invitrogen) were added to each well followed by 
visualization under a fluorescent microscope (Carl Zeiss).  For cell counts, 5000 
cells/field (4 fields per condition) were counted to determine live (calcein AM 
positive) and dead (ethidium homodimer-1 positive) cells, and expressed as the 
percentage of live cells per field.  Counts were assessed in 3 independent experiments. 
 
Proliferation assay 
To label OPCs in S-phase, bromodeoxyuridine (BrdU) (10 µM) was added to the 
culture medium for 17 hr. Cells were then fixed in 4% PFA for 5 min. After washing, 
the DNA was denatured in 2 M HCl for 15 min, followed by neutralization in 0.1 M 
sodium borate for 15 min. Cells were then washed and permeabilized with 20% 
normal goat serum/0.4%Triton X-100 for 30 min. The cells were incubated with a 
monoclonal anti-BrdU antibody (1:40; GE Healthcare, Little Chalfont, 
Buckinghamshire, UK) for 1 h, followed by a goat anti-mouse IgG conjugated with 
FITC (1:500) for 30 min. The final antibody incubation included Hoechst 33342 
(1:2000; Invitrogen) to visualize the nucleus of all cells. For all assays, six wells were 
counted and assays were performed at least three times with independent cell 
isolations. All results are shown as percentage of BrdU positive cells +/-SEM. 
Statistical significance was determined using one-way ANOVAs. 
 
Protein isolation and Western Blots 
Optic Nerve-derived rat OCs were grown in 10cm PDL-coated plates until confluence 
(after passage 1) and then matured overnight in SATO without growth factors. Cells 
were treated with LIF for 48 hours (2 doses 24 hrs apart) or left untreated, and cells 
and media were harvested in protein lysis buffer (1% Triton-X-100, 1% sodium 
deoxychlorate, 0.1% SDS 150mM NaCl, 10mM Tris pH 7.5, (RIPA), with 1mM 
iodoacetic acid, 50µg/mL Soybean trypsin inhibitor, 20µg/mL aprotinin, 1mM PMSF, 
and 1 Complete Protease Inhibitor Mini Tablet, Roche). First we collected 7 ml of 
supernatant and added 3 mL of protein lysis buffer. Then the cells were washed with 
cold PBS (GIBCO) twice, lysed in 1mL of protein lysis buffer and harvested using a 
cell-scalper. Both samples were left 30 mins on ice then centrifuged at 13,000rpm at 
4oC for 15 min. The BCA Protein Assay (Pierce) was used to determine protein 
concentrations. A total of 5µg protein of each cell lysates and 50µg protein from each 
supernatant lysate was separated on 16% Tricine SDS-PAGE gels (Invitrogen) and 
transferred to PVDF membranes (Pall Corporation) at 25V for 2 hrs. The blots were 
blocked in 2% BSA in TRIS-buffered saline containing 0.1% Tween 20 (TBST) for 1 
hour, and then incubated overnight at 4oC with primary antibodies including goat 
polyclonal anti-Secretogranin 2 antibody (M20, Santa Cruz) at 1:200, goat polyclonal 
anti-VGF antibody (Santa Cruz) 1:200, rabbit anti-IGF 2 antibody (Gropep) 1:1000, 
anti-Galanin antibody (H80, Santa Cruz) 1:200, goat anti-Gal R2 (K20, Santa Cruz) 
1:200.  Note that in order to ensure specificity of the H80 anti-galanin antibody for 
Western blotting we also conducted pre-absorption experiments using recombinant 
galanin (result not shown). Blots were washed 6 times for 5 min in TBST, all blots 
were then incubated with secondary antibodies, peroxidase-labeled anti-rabbit or anti-
goat IgG at 1:5000 (CST) for 1 hr at RT. Bands were visualized using Amersham 
Hyperfilm ECL chemiluminescent substrate (Amersham Biosciences). As an 
additional loading control, all transfer membranes were stained with amido black and 
photographed. 
 
For the signaling phosphorylation analyses, CG4 cells were grown to confluence in 
P10 (Nunc) plates in SATO media for 72 hrs with NT3 and PDGF, then differentiated 
by PDGF withdrawal for 48 hrs. Recombinant galanin was added at 1µg/ml for 
between 5 and 120 minutes, with an untreated culture used as a “0” minute control. 
Cells were washed in cold PBS and lysates collected in 100ul RIPA lysis buffer with 
complete protease and phosphatase inhibitor tablets (Roche) using cell scrapers. 
Samples of 50 µg of protein lysate in buffer were separated by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis and transferred to nitrocellulose 
membranes using iBlot (Invitrogen). Proteins were visualized using the Odyssey 
Infrared Imaging System and quantification tools (LI-COR Biosciences). Primary 
antibodies were against p-rpS6 (Ser-240/244; Cell Signaling #2215), rpS6 (Cell 
Signaling #2217), pS-Akt (Ser-473; Cell Signaling #4058), Akt (Cell Signaling 
#9272), pErk1/2 (p44/42 MAPK, Thr-202/Tyr-204; Cell Signaling #9101), and 
Erk1/2 (Cell Signaling #4695). Secondary detection antibodies were Donkey anti-
Rabbit IgG (IRDye 800CW) and Donkey anti-Mouse IgG (IRDye 680RD). 
 
Immunocytochemistry: 
Mature OCs in 24-well plates grown on cover slips were used for 
immunocytochemistry. The cells were washed in PBS and then fixed by adding 4% 
PFA for 10 minutes, followed by three washes with PBS. Then, the cells were 
blocked in 10% Normal Goat Serum/0.3% Triton X in PBS for 2 hr and then stained 
with primary antibody in the same block: mouse anti-CNPase monoclonal antibody 
(Chemicon) 1:500; rabbit polyclonal anti-Secretogranin 2 antibody (M20, Santa Cruz) 
1:500; or rabbit anti-Galanin antibody (H80, Santa Cruz) 1:200,for 2 hr at RT, 
followed by 3 washes with PBS (repeated twice for dual epifluorescence staining). 
Secondary antibodies were then applied to the cells in the same blocking solution, 
including, anti-mouse Alexafluor 599 (1:400), anti-rabbit fluorescein conjugated 
secondary antibody (1:400, Jackson) or anti-goat fluorescein conjugated secondary 
antibody (1:400, Jackson) together with Hoechst 33342 nuclear stain (1:10,000) at RT 
for 1 hr. After a further 3 PBS washes, the cover slips were mounted on slides using 
Mowiol (Merck), and photographed using a Zeiss Axioplan 2 Imaging system 
(Axiovision Software Release 4.4).    
 
Immunohistochemistry: 
For fluorescence immunohistochemistry, corpus callosum sections were incubated 
with blocking solution (2% serum (NGS or NDS), 0.5% BSA, 0.1% Triton-X 100 in 
0.1M PBS) for 1h at RT, and then incubated with the appropriate primary antibodies 
in blocking solution overnight at 4°C: rabbit anti-Galanin  (H80, Santa Cruz,1:200), 
goat anti-galanin (Abcam, 1:100), mouse anti-CNPase monoclonal antibody 
(Chemicon, 1:500), rabbit anti-IBA (Wako-Chem, 1:1000), mouse anti-APC (CC-1; 
Calbiochem, 1:100), rabbit anti NG2 (Millipore, 1:500), mouse anti-GFAP (Millipore, 
1:200), rabbit anti-caspase 3active (Millipore, 1:200). Sections were washed thrice in 
PBS and then incubated with the appropriate secondary antibodies: goat anti-rabbit 
IgG fluorescein-conjugated secondary antibody (1:400, Jackson), goat anti-mouse 
IgG rhodamine-conjugated secondary antibody (1:400, Jackson), donkey anti mouse 
IgG aminomethyl coumarin acetate conjugated secondary antibody (1:50, Jackson), 
donkey anti-rabbit IgG rhodamine conjugated secondary antibody (1:200), donkey 
anti-goat fluorescein-conjugated secondary antibody (1:200) for 2 hours at room 
temperature.   Cell nuclei were labeled with Hoechst 33342 (1:10,000, Invitrogen, 
Calsbad, CA) in PBS for 10 min at RT and slides were mounted with Mowiol solution 
(Merck) and coverslipped. Images of stained corpus callosum sections were captured 
as above.  The percentage of IBA1 labeling within the corpus callosum was measured 
using methods modified from Gresle et al. (2008), where the area of cell nuclei are 
measured using the threshold and measure functions in ImageJ software (Verison 
1.45s)    
 
Statistics 
All cell culture assay counts, histological counts and gene expression results were 
assessed for difference of means using Graphpad Prism 5 for MAC (Version 5). Date 
distributions were verified as normal. If there were more than two experimental 
conditions, difference of means was assessed using ANOVA, with Tukey’s multiple 
comparison test. If there were only two conditions, unpaired t-tests were used to 
compare means. Differences of variance between samples were assessed using 
Bartlett’s test (ANOVA) or F-tests (t-tests). 
 
Results  
 
Cytokine-mediated changes in gene expression within oligodendrocytes 
We initially assessed the potential mechanisms of action of three key cytokines 
known to promote the survival of OCs, namely insulin, NT3, and the interleukin-6 
family member, LIF. To assess this, we immuno-purified OC precursor cells from P6 
rat optic nerves (Barres et al. 1992), expanded the cells in platelet-derived growth 
factor (PDGF), at 5ng/ml, differentiated them by PDGF withdrawal for 48 hours, and 
then exposed the cells to 4 different conditions for 8 hours: basal media only, or basal 
media supplemented with either LIF (100ng/ml), NT3 (5ng/ml) or insulin (5µg/ml). 
We harvested RNA from three independent replicate experiments (two independent 
replicates for the basal condition), and utilized gene expression microarrays 
(Affymetrix) to compare differential gene expression profiles between conditions. 
Lists of significantly differentially expressed (DE) genes (p values less than 0.01 and 
fold changes of 2 fold or greater, ANOVA) were generated for each comparison 
between control and treatment groups (Tables 1-3, with 3-fold or greater shown for 
LIF versus control). There was little concordance between genes induced by LIF, 
insulin or neurotrophin-3. Some 95 probe sets were DE between control and LIF-
treated cells, 15 between control and NT3-treated cells and 35 between control and 
insulin-treated cells. Of the 95 genes DE in the LIF condition, 83 were increased and 
12 decreased. Eighty-six of the DE genes were uniquely regulated in the LIF 
condition. Nine probe sets changed in multiple growth factor conditions (see Tables 
1-3), namely LIF and Insulin (n=2, Probeset ID 1376891 and Ate1); LIF and NT3 
(n=6, Probeset ID 1375268, Smg5, Dcun1d1, Mobp, Gdpd1 and Appbp2) or all three 
(n=1, Probeset ID 1380200).  
 
LIF regulates genes encoding secretory proteins 
The list of 95 differentially expressed probe sets following LIF treatment was then 
mined for gene ontology (GO) terms in order to identify major biological themes 
using GOminer (Zeeberg et al. 2003). The enrichment analysis from GOminer was 
then analysed using Vennmaster (Kestler et al. 2008). Overrepresented GO categories 
for “Cellular Component” were filtered with a p-value of less than 0.02 and category 
size bracket of 70-400. We identified 14 overlapping categories containing a total of 
17 genes. Notable significantly over-represented categories were “cytoplasmic 
vesicles”, “secretory granules” and “extracellular space”. In particular, we noted from 
within these categories that LIF induced the expression of genes encoding the 
secreted peptides galanin, VGF, calcitonin-related peptide (CRP), insulin-like growth 
factor 2 (IGF2) and the secretory granule protein secretogranin II (Figure 1a).  
 
We performed real-time PCR validation of these five upregulated genes using 3 
independent OC culture replicates, comparing exposure to LIF for 8 hrs with exposure 
to insulin for 8 hrs, and confirmed highly significant LIF-induced gene expression 
increases for all of them (Fig 1b). We also compared RNA expression of the same 5 
candidates in independent duplicate OC cultures treated with either LIF in 
combination with insulin or insulin alone for 24 hrs, and again demonstrated 
significant LIF-induced gene induction for all 5 RNA species (data not shown).  
 
LIF-induced secretion of the neuropeptide galanin in oligodendrocytes in vitro 
We next sought to identify whether LIF-mediated induction of these five mRNA 
transcripts in OC also resulted in upregulation of their respective encoded proteins. In 
order to maximise cellular survival, we chose to conduct these experiments in OC 
cultures in the presence of insulin. We exposed high-density OC cultures to either LIF 
(100ng/ml) or “no added factor” for 48 hrs and harvested the culture medium. We 
concentrated the OC-conditioned medium by size-selective centrifugation and 
performed Western blots to assess for the presence and LIF-induced regulation of 
galanin, CRP, VGF, IGF-2 and secretogranin-2. In duplicate experiments, an anti-
galanin antibody detected a strong LIF-induced increase in a band at approximately14 
kD (Fig 2a), corresponding to the reported size of secreted preprogalanin (Lang et al. 
2007; Yu et al. 2007). We also exposed high-density cultures of the oligodendroglial 
cell line, CG4, to either LIF (100ng/ml) or “no additional factor” for 48 hrs (all in the 
presence of insulin) and once again identified a 14 kD band by Western blot analysis 
that was significantly induced by LIF. In order to assess cellular specificity of the 
response, we also collected conditioned medium from duplicate primary rat astrocyte 
cultures exposed to either LIF or “no added factor” for 48 hrs and detected no 
significant LIF-induced increase of the same 14 kD band (Fig 2a). In these 
experiments, we could also detect expression of two isoforms of secretogranin-2 and 
demonstrated possible regulation of the 30kD isoform of secretogranin-2 by LIF 
exposure (data not shown), consistent with prior reports showing regulation of a 30kD 
isoform in melanocytes exhibiting a secretory phenotype when compared to non-
secretory melanotrope cells (Peinado et al. 2006). Using immunohistochemistry 
(IHC), we were also able to visualize LIF-mediated induction of galanin and 
secretogranin-2 in OC in vitro in a topographic pattern consistent with their location 
in cytoplasmic granules (Fig.3, panels a-d).  
 
We also detected IGF2 in the conditioned OC medium, but this was not regulated by 
LIF (Fig. 2b). We found no evidence for LIF-mediated secretion of CRP or VGF 
proteins using Western blots (data not shown). 
 
LIF-induced expression of the neuropeptide galanin in oligodendrocytes in vivo 
We next sought evidence for LIF-induced galanin secretion in OC in vivo. We 
utilized the cuprizone model (Matsushima and Morell 2001), which produces a toxic 
demyelinating lesion in the corpus callosum. Of relevance to our focus, cuprizone is 
known to induce the production of both LIF and CNTF in the demyelinating corpus 
callosum (Emery et al. 2006). We exposed wild type C57Bl6 mice (n=6), LIF 
knockout mice (n=5), CNTF knockout mice (n=4) and LIF/CNTF double knockout 
mice (n=2) to 18 days of cuprizone ingestion, an early demyelinating time-point. We 
performed dual fluorescent staining for galanin and the OC marker CNPase in the 
caudal corpus callosum of these mice and compared staining patterns to those 
obtained in control mice of the same genotypes without cuprizone challenge 
(n=2/genotype). We assessed the central corpus callosum in three coronal sections per 
mouse. In control mice, we did not detect any co-localisation of galanin and CNPase 
staining (data not shown). In cuprizone-exposed wild-type mice, 76% (SE +/-9%) of 
OC expressed galanin (Fig 3e), whereas in LIF knockout mice, only 18% (SE +/-
10%) of OC expressed galanin (Fig 3f, p=0.008 compared to wild-type mice). In 
CNTF/LIF double knockout mice, galanin expression was detected in 9% (SE +/-5%) 
of CNPase positive cells (p=0.04 compared to wild-type mice). In contrast, 66% (SE 
+/-17%) of CNPase positive cells expressed galanin in CNTF knockout mice, not 
significantly different from wild-type mice (p=0.47). 
 
To independently confirm cuprizone-induced OC expression of galanin, we assessed 
sections from transgenic mice expressing the fluorophore dsRED under the control of 
the OC-specific Proteolipid protein promoter (PLP-dsRED, Hirrlinger et al, 2005). 
Six transgenic animals were exposed to cuprizone for three weeks, killed and 
processed for galanin immunohistochemistry. As a positive staining control, we 
identified galanin-staining in nerve fibres and cells of the paraventricular thalamic 
nucleus (Fig 3g), and we demonstrated that PLPdsRed positive OC in this area, which 
is not affected by toxic cuprizone demyelination, did not express galanin (Fig. 3g). 
Oligodendrocytic expression of galanin was restricted to the caudal corpus callosum, 
where 75% (SE +/-11%) of PLPdsRed positive cells expressed the neuropeptide (Fig 
3h) and high power light microscopy revealed an intracellular, granular pattern of 
galanin staining, consistent with galanin presence in OC secretory vesicles (Fig 3i). It 
was also observed that galanin co-labeled with a small number of microglia/ 
macrophages within the demyelinated CC (Fig S1 A), but not GFAP labeled 
astrocytes (Fig S1 A) or NG2 labeled OC progenitor cells (Fig S1 B).  Very few 
activated caspase 3 (apoptotic) labeled OCs were observed in the CC after 3 weeks of 
cuprizone treatment, and none of these were found to co-label with galanin (Fig S1 
C).  
 
Galanin promotes the survival of GalR2 expressing oligodendrocytes 
Having established that OCs regulate galanin expression during central 
demyelination, we next assessed whether, as a secreted protein, galanin might also 
exert autocrine/paracrine effects. We therefore assessed the survival of post-mitotic 
rat OC in vitro 48hr after addition of recombinant galanin at 0.01nM, 0.1nM, 1nM, 
10nM, 100nM  and 1 M, compared to a basal media (Sato only) control condition. 
Galanin concentrations at or above 1nM significantly increased OC survival. The 
survival effect was maximal at 1nM galanin, which increased OC survival by 50%, 
p=0.0008 (ANOVA). An independent replicate experiment confirmed this result, with 
the 1nM galanin condition increasing OC survival 46% above baseline at 48 hrs 
(p=0.005). In a third independent experiment, we compared OC survival induced by 
galanin with that induced by known OC survival factors, namely LIF, NT3 and 
insulin after 48 hours of exposure to each factor. The survival of OC cultured with 
galanin was 87% above the Sato basal media condition (p=0.004), and was not 
significantly different from the survival effect induced by LIF or NT3 (Fig 4a), 
although less than that produced by insulin. The survival effect of 1 nM galanin on 
OC was still apparent at 72 hrs in culture compared to the Sato basal media condition 
(p=0.016, Fig 4b).   
We were also able to demonstrate that exogenous galanin (1nM) can promote the 
survival of OCs derived from CG4 cells at 72 hours of exposure to TNFa (100ng/ml) 
(figure S1 D; Galanin and TNFa condition (40.6 ± 1.4%) vs TNFa only (17.8 ± 
5.1%)).       
 
We next assessed whether galanin promoted proliferation of actively dividing OPC. 
We did not detect a proliferative effect of galanin compared to the Sato media 
negative control condition, whereas the known OPC mitogen platelet-derived growth 
factor (PDGF, Raff et al, 1988) at a known maximal concentration of 5ng/ml, induced 
division of an estimated 45% of all OPC within 24 hrs. Galanin combined with half-
maximal PDGF (2.5ng/ml) also did not promote OPC division above the level seen 
with half-maximal PDGF alone (Fig. 4c).  
 
In neurons, galanin is known to signal via three different galanin receptors (GalR1, 2 
and 3), all of which are G-protein-coupled receptors (reviewed by Hokfelt, 2005).  
Having demonstrated a significant survival effect of galanin upon OC, we next sought 
evidence of expression of any of the three known galanin receptors in these cells. The 
mRNA levels of GalR2 was 100 fold greater than GalR3 and 1000 fold greater than 
GalR1 in OC grown in insulin for 48 hrs (Fig. 4d).  
 
Galanin signaling in OC phosphorylates ERK1/2 
In order to investigate signaling pathways potentially activated by galanin in OC, we 
performed a time-course experiment to assess phosphorylation of ERK1/2, AKT and 
S6 in CG4 cells in triplicate. In each experiment, ERK1/2 was rapidly phosphorylated 
after administration of recombinant galanin (1g/ml), whereas there was no consistent 
evidence for AKT or S6 phosphorylation (Fig 4e).  
 
LIF-induced oligodendrocyte survival is dependent on galanin 
 
Given our demonstration of LIF-mediated galanin secretion and of galanin-induced 
survival of OC, we hypothesized that LIF-induced survival of OC could be partially 
or completely dependent on galanin secretion. To test this hypothesis we 
contemporaneously assessed the survival of post-mitotic OC differentiated from OPC 
isolated from wild type or galanin knockout (Gal-KO) mice. In independent duplicate 
experiments, the cells were plated at high density in Sato media with or without LIF 
(100ng/ml). High density culture was used because we hypothesized that LIF-
mediated galanin secretion into the culture medium could then act as an OC survival 
factor, an effect that could not be observed with low-density or clonally plated cells in 
standard survival assays. OC survival in Sato media (basal condition) was no different 
between genotypes at 48, 72 or 96 hours subsequent to plating of the OPC. As 
expected, LIF induced a pro-survival effect in wild-type OC cultures, but, 
importantly, LIF did not potentiate the survival of Gal-KO OC cultures at any time-
point (Figure 5). In contrast, we confirmed that galanin itself retained its survival 
effect in OC derived from GAL-KO mice.  At 48 hrs, 1nM galanin increased survival 
of these OC by 45% above SATO alone, (SD 32-56%, p<0.01, n=8 plates of 16 
wells/group) and the effect was maintained at 72 hrs (mean 77% survival increase, SD 
53-99%, p<0.01, n=8 plates of 16 wells/group, 100 cells/well), thus demonstrating 
that the lack of LIF-mediated survival in GAL-KO OC is not secondary to altered 
galanin-signaling in the KO cells.  
Secondly, we established small inhibitory RNA mediated galanin knockdown in rat 
OC in order to independently verify the above survival experiment. We used rat OC 
subjected to either si-RNA mediated knockdown of galanin, or non-targeting siRNA 
transfection as a control, in high-density cultures. We conducted independent 
triplicate experiments. We plated either non-targeting siRNA or galanin siRNA 
transfected OC in basal media plus insulin, and compared cell survival with or 
without addition of LIF (100ng/ml). In OC transfected with non-targeting siRNA, LIF 
addition produced an average 60% survival increase at 48 hrs (Individual results: 
+80%, +25% and +75%, compared to no LIF addition, p=0.04, T-test), and this was 
abolished in galanin siRNA transfected cells, with an average 0% survival  (+20%, -
20%, +/-0%, P=NS) in LIF-treated versus untreated OC cultures).  
  
Galanin KO mice exhibit normal myelination but develop more severe callosal 
demyelination during cuprizone exposure 
Since we have shown that galanin is expressed in callosal OC during cuprizone-
induced demyelination (see above), and that it is a survival factor for OC in vitro, we 
next assessed the potential significance of galanin expression during toxic 
demyelination in vivo. We exposed wild type and (Gal-KO) mice to cuprizone for 4 
weeks and assessed the density of myelinated axons in the severely demyelinated 
caudal corpus callosum. We performed experiments with a total of 12 mice/group. In 
the caudal mid-line corpus callosum (Fig 6a,b,c), Gal-KO mice had significantly 
fewer myelinated axons (mean 56, sd +/- 7 myelinated axons/field) than wild-type 
mice (mean 125, sd +/- 15 myelinated axons/field), p=0.0004 (Fig.5d). Of note, the 
density of myelinated axons in the caudal mid-line corpus callosum was not different 
in control wild-type (mean 2020, range 1700-2090 myelinated axons/field) and Gal-
KO mice (mean 2100, range 1650-2380 myelinated axons/field; n=6) in the absence 
of cuprizone challenge. 
We next assessed OC density in mice (n=6/group). In the caudal, cuprizone affected 
corpus callosum (identified by the presence of macrophage infiltrates), Gal-KO mice 
showed a 2.4-fold reduction in CC1-positive OC density, with a mean OC density of 
46.4/mm2 (SE 8.2/mm2) in GAL-KO mice (n=6) and 125/mm2 (SE 39/mm2) in wild-
type mice (n=6), P=0.05.  
In the rostral CC of cuprizone treated mice, mean OC density in Gal-KO mice (n=6) 
was 433/mm2 (SE 71/mm2), and 461/mm2 (SE 60/mm2) in WT mice (n=6), P=0.77.  
In the mid-sagittal section, the maximum width of the cuprizone-affected caudal 
corpus callosum, an indicator of callosal swelling, was no different between Gal-KO 
mice and healthy wild-type mice (data not shown), indicating that axon density 
changes were not a function of altered inflammation-associated edema in the different 
genotypes.  The percentage of callosal area labeled with IBA1 was not different 
between WT (25.1 ± 6.8%) and Gal-KO (26.2 ± 5.0%) mice after 3 weeks of 
cuprizone treatment.     
 
 
Discussion 
 
In this study, we report a number of findings of significance with respect to OC 
biology and survival. Firstly, three cytokines known to be important for OC survival 
induce the transcription of a range of genes. However these down-stream cytokine-
dependent gene expression profiles are disparate, suggesting that there are probably 
no common survival pathways that underlie their biological activity. Secondly, we 
report that LIF-treated post-mitotic OC secrete a number of neuropeptides, in 
particular galanin, at the mRNA and protein level. Our experiments confirm LIF-
induced galanin protein synthesis and secretion in primary rat OC, but not in 
astrocytes.  In vitro, galanin itself was shown to be a survival factor for OC, and its 
induction was required for LIF-mediated OC survival in high-density culture. In vivo, 
galanin expression was induced in OCs in response to cuprizone-induced 
demyelination and also reduced the extent of myelin loss in this disease model. We 
also demonstrated that galanin induction in corpus callosum OC during cuprizone-
induced demyelination is largely dependent on endogenous LIF, concordant with our 
in vitro results.  
 
We have previously shown that LIF mRNA is markedly upregulated in the corpus 
callosum of mice challenged with cuprizone. The LIF knockout mice exhibit 
increased demyelination compared to wild-type littermates (Emery et al. 2006) 
whereas systemic administration of recombinant murine LIF reduces demyelination in 
comparison to placebo-treated mice (Marriott et al. 2008). Based on the observations 
from our current study, we postulate that LIF mediates myelin protection during 
cuprizone toxicity through induction of galanin secretion in OCs. It is also possible 
that galanin could have targeted commissural axons within the corpus callosum to 
make them more receptive to remyelination or to resist demyelination after cuprizone 
challenge. The distinction between these possibilities or the determination that both 
are relevant will require the use of conditional knockout strategies in which the 
relevant Gal receptors are selectively ablated from either neurons or OCs 
  
In hippocampal slice cultures, recombinant galanin rapidly phosphorylates both 
ERK1/2 and AKT (Elliott-Hunt et al. 2007). In OC, we have demonstrated that 
galanin rapidly induces ERK1/2 phosphorylation, but not AKT or rpS6 
phosphorylation, suggesting some differences in signaling mechanisms between 
neurons and OC. This provided direct evidence of galanin signaling in OC. The three 
galanin receptors are differentially expressed in OC, with the relative expression 
profiles suggesting that GalR2 is likely to be the relevant receptor. However, Zhang 
and coworkers reported a two-fold upregulation of GalR1 mRNA expression in the 
cuprizone-affected corpus callosum at 6 weeks compared to tissue obtained from 
healthy controls (Zhang et al. 2012). Ultimately, galanin receptor mRNA change may 
or may not indicate the precise signaling mechanism, and thus, future work should 
include the conditional deletion of one or more of the receptor species in OC, or the 
assessment of OC responses to specific galanin agonists to further delineate potential 
galanin receptor specificity and inform therapeutic studies.  
 
 
Collectively, our results demonstrate induction of peptide secretion as a novel and 
biologically significant cellular function in post-mitotic OC. We show that OCs 
upregulate expression of the neuropeptide galanin, and that this response occurs in 
vivo in the context of demyelinating injury. We also demonstrate that, in vitro, galanin 
secretion by OC probably sub serves an autocrine or paracrine survival loop and that 
in vivo OC-derived galanin directly reduces the extent of demyelination in the 
cuprizone injury model. We further show that galanin upregulation in OC in this 
model is downstream of endogenous LIF regulation, a biological response that was 
previously described in neurons. We conclude that galanin signaling could be an 
important determinant of outcome in central demyelinating disease and, as such, 
could represent an important therapeutic target for multiple sclerosis.  
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Figure Legends: 
Figure1: LIF-induced gene expression changes in oligodendrocytes in vitro 
Figure 1A: Gene array expression levels of selected candidate genes classified by the 
cellular process code “secretion” that were significantly up-regulated in LIF 
conditions (n=3) compared to no growth factor control (n=2), insulin (n=3) or NT3 
(n=3). The Y-axis in each panel is the relative expression (log base 2) for each 
condition, averaged by least squared mean. 
Expression levels of each of the 6 genes were a least 2-fold greater in the LIF 
condition than the other conditions, *=p<0.01, for specific p-values see Table 1 (error 
bars: SEM).  
Figure 1B: Real-time PCR validation: relative oligodendrocyte RNA expression 
levels of the same six genes after LIF exposure for 8hrs, compared to insulin exposure 
for 8 hrs (n=3 independent replicates). Lowest expression level in insulin condition 
was set to 1, and results illustrate the mean (SD) expression change, p<0.05 for each 
gene expression comparison between LIF and Insulin conditions.   
 
Figure 2: LIF-induced protein changes in oligodendrocytes and conditioned medium 
Figure 2a: Concentrated media of rat oligodendrocyte (OC, upper panel) and CG4 cell 
cultures (middle panel), cultured for 48 hrs, were subject to Western blotting using 
anti-galanin antibodies. Cultures exposed to LIF at 100ng/ml showed marked 
upregulation of a 14kD band consistent with secretion of preprogalanin in comparison 
to cells exposed only to insulin (Nil). Rat astrocytes (lower panel) did not exhibit the 
same LIF-induced response (100ng/ml, 48 hrs). Independent replicate experiments are 
shown in each blot, and major protein bands visualized by Amido Black stains of the 
same membranes are shown as loading controls. Figure 2b: Western blot of 
concentrated media of OC cultures exposed to either LIF or insulin showed evidence 
of a band at 7kD, consistent with IGF2 secretion. Unlike preprogalanin, IGF2 levels 
were not increased by LIF at the protein level.  
 
Figure3: Galanin-containing secretory granules in oligodendrocytes are induced by 
LIF in vitro and in vivo 
CNPase positive oligodendrocytes (OC) (red) in culture containing insulin (panel a) 
showed no galanin expression (green). After exposure to LIF (100ng/ml, 48 hrs), 
CNPase positive OC (panel b) showed punctate cytoplasmic galanin staining (arrow). 
CNPase positive OC (c, red) showed some granular cytoplasmic staining for 
secretogranin-2 (green), but this was markedly upregulated after 48hrs of LIF 
exposure (panel d, arrow). CNPase (red) positive OC were visualized in linear arrays 
in the corpus callosum (cc, panels e,f). After in vivo exposure to cuprizone for 18 
days, 75% of OC in the corpus callosum of wild-type mice exhibited cytoplasmic 
galanin immunoreactivity (green, panel e, arrows), whereas OC in the cc of LIF 
knockout mice exhibit no galanin positivity (panel f). Images in panels g-i are from 
PLP-dsRED mice expressing the dsRED fluorophore, stained with anti-galanin 
antibody (green). After 21 days of systemic cuprizone exposure, in the paraventricular 
thalamic nucleus (panel g), galanin-positive neuronal cell bodies and fibres were seen 
next to galanin-negative OC (red). In contrast, in the demyelinating cc around 75% of 
PLP-ds red positive OC expressed cytoplasmic galanin (panel h, arrows). Occasional 
dsRED negative cells also expressed galanin (arrowhead). Panel i: high power image 
from the cc illustrating granular cytoplasmic galanin staining in a dsRED positive 
cell. Scale bars for panels a-f,i=10µm; for panels g and h=50 µm. 
 
Figure 4: Galanin is a survival factor for oligodendrocytes 
Figure 4a and 4b: Oligodendrocyte (OC) survival 48 or 72 hrs after addition of either 
recombinant rat galanin (3.2ng/ml=1nM), LIF (100ng/ml), NT3 (5ng/ml) or insulin 
(5µg/ml), compared to basal media only. Post-mitotic OC were plated at 100 
cells/well (20 wells per condition), and the data are presented as live cell counts 
(mean +/-SD). Each growth factor condition significantly increased survival above 
basal (*p<0.05, ***p<0.001, ANOVA). Figure 4c: To assess any proliferative effect 
of galanin, oligodendrocyte progenitor cells (OPCs) were exposed to galanin (1nM), 
PDGF (5ng/ml), PDGF (2.5 ng/ml) and the combination of PDGF (2.5ng/ml) and 
galanin (1nM). Maximal-dose PDGF (5ng/ml) induced around 40% BRDU-positivity, 
whereas galanin induced none. The combination of half-maximal dose PDGF and 
galanin did not promote OPC proliferation above that induced by half-maximal dose 
PDGF alone (*** denotes significant difference to basal proliferation rate, p<0.001, 
ANOVA, data shown are mean % +/-SD). Figure 4d: Relative mRNA expression of 
the three known galanin receptor species in post-mitotic OC assessed by real-time 
PCR. GalR2 mRNA is around 900 fold more abundantly expressed than the other 
receptor species (mean of three separate experiments shown, lowest GalR1 expression 
was standardized to 1, error bars = SD, *** denotes significant difference compared 
to GalR1 expression, p<0.001, ANOVA). Figure 4e: Time course of phosphorylation 
of key signaling intermediaries after galanin (1µg/ml) exposure in vitro. ERK 1/2 is 
rapidly phosphorylated, whereas AKT and S6 phosphorylation levels are unaltered. 
Representative images of duplicate experiments shown.   
 
Figure 5: LIF-mediated oligodendrocyte survival in vitro is galanin-dependent 
Mouse oligodendrocyte progenitor cells from wild-type (WT) and galanin knockout 
(Gal KO) mice were expanded in vitro and then plated under differentiating 
conditions at high density in Sato (Nil) or Sato plus LIF (100ng/ml). Live cells were 
counted at 48, 72 and 96 hrs under bright field microscopy (average of 10 fields in 
each of two plates/condition).  Results were combined from independent duplicate 
experiments, and survival is expressed as mean (+/-SD) live cell count/field. Addition 
of LIF to WT oligodendrocyte (OC) cultures increased survival at 48, 72 and 96 hrs. 
Addition of LIF to Gal KO OC cultures did not produce a survival effect at any time-
point. (***p<0.001; *p<0.05, ANOVA).  
 
Figure 6: Galanin knockout mice exhibit more severe cuprizone demyelination.  
Galanin knockout (KO) mice (n=11) and wildtype mice (n=11) were fed cuprizone 
0.2% in milled chow for 4 weeks. Myelinated axon density was quantitated in the 
severely demyelinated caudal portion of the corpus callosum (Fig 6a, black square) in 
two fields/mouse from methylene-blue stained thin sections (6b,c). Panel 6b 
illustrates severe loss of myelinated axons in a Galanin KO mouse, panel 6c shows 
less severe loss from a wild-type mouse, arrowheads indicate myelinated axons, scale 
bars =40 µm, unit area=17400µm2. Galanin KO mice had less residual myelinated 
axons than wild-type mice (Fig 6d, average myelinated axon densities from individual 
mice shown in scatterplot, lines indicate means, ***p<0.001, t-test). 
 
 
Table 1: Probe sets with differential expression between control and LIF treatment 
(p<0.01 and fold change >2). Positive fold changes indicate increased expression in 
control samples compared to treated samples. Probeset ID refers to Affymetrix probe 
sets.  
 
Table 2:  Probe sets with differential expression between control and NT3 treatment 
(p<0.01 and fold change >2). Positive fold changes indicate increased expression in 
control samples compared to treated samples. Probeset ID refers to Affymetrix probe 
sets.  
 
Table 3: Probe sets with differential expression between control and Insulin treatment 
(p<0.01 and fold change >2). Positive fold changes indicate increased expression in 
control samples compared to treated samples. Probeset ID refers to Affymetrix probe 
sets. 
 
Figure S1: Galanin co-labeling studies, and oligodendrocyte tumor necrosis factor 
alpha (TNFa) survival assay.  In curpizone treated mouse corpus callosum, we show 
that galanin (A, green) does not co-label with glial fibrilary acidic protein positive 
astrocytes (A, GFAP, blue), but does co-label with a few IBA-1 positive 
microglia/macrophages (A, red, arrows).  Galanin (green) was not found to co-label 
with NG2 positive oligodendrocyte lineage cells (B, red, arrow), or activated caspase 
3/CC-1 double positive oligodendrocytes (C, red and blue respectively, arrows).  In 
D, exogenous galanin was found to promote the survival of oligodendrocytes derived 
from CG4 cells in the presence of TNFa.  Cells were seeded at a density of 5000 
cells/well in an 8 well chamber slide, and exposed to galanin (1nM), TNFa 
(100ng/ml), or galanin and TNFa for 72 hours.  For live/ dead cell counts, 5000 
cells/field (4 fields per condition), in 3 independent experiments, were assessed. Data 
are presented as mean percentage of live cells ± SEM (*P<0.05, **P<0.01, ANOVA).       
 







